KCPC yields 2000000.00% · PFE yields 6.13%● Live data
📍 KCPC pulled ahead of the other in Year 1
Combined, KCPC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KCPC + PFE for your $10,000?
Key Capital Corporation, a development stage company, engages in the mining and mining industry financing business worldwide. The company operates as a streaming, structured finance, and equity funder of mining projects through funding agreements for an interest in the production of mines containing gold, silver, base metals, or energy products. It is also involved in funding resource and energy projects through its online lending platform. In addition, the company, through its subsidiary, GeoGlobal Resources, Inc., engages in the exploration and production of oil and gas in three blocks in the onshore Cambay Basin, as well as the gas production testing in offshore Deen Dayal West Field in the Krishna-Godavari Basin. The company was formerly known as Elite Computer Services, Inc. and changed its name to Key Capital Corporation in April 1998. Key Capital Corporation was founded in 1996 and is headquartered in New York, New York. Key Capital Corporation operates as a subsidiary of KeyCorp.
Full KCPC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.